rivastigmine has been researched along with Huntington Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Bolle, N; Bucik, V; Kobal, J; Sešok, S; Vodušek, DB | 1 |
| Kumar, A; Kumar, P | 1 |
| Kobal, J; Mesec, A; Pirtosek, Z; Rot, U; Sever, A | 1 |
| de Tommaso, M; Difruscolo, O; Sciruicchio, V; Specchio, LM; Specchio, N | 1 |
1 review(s) available for rivastigmine and Huntington Disease
| Article | Year |
|---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |
2 trial(s) available for rivastigmine and Huntington Disease
| Article | Year |
|---|---|
Cognitive function in early clinical phase huntington disease after rivastigmine treatment.
Topics: Adult; Cognition Disorders; Dementia; Double-Blind Method; Female; Humans; Huntington Disease; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychometrics; Rivastigmine; Slovenia | 2014 |
Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
Topics: Adult; Aged; Cognition Disorders; Demography; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Neuroprotective Agents; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index; Trinucleotide Repeat Expansion | 2004 |
2 other study(ies) available for rivastigmine and Huntington Disease
| Article | Year |
|---|---|
Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Topics: Administration, Oral; Animals; Behavior, Animal; Brain; Brain Chemistry; Cholinesterase Inhibitors; Corpus Striatum; Huntington Disease; Lipid Peroxidation; Male; Maze Learning; Mitochondria; Motor Activity; Neuroprotective Agents; Nitrites; Nitro Compounds; Oxidative Stress; Phenylcarbamates; Propionates; Rats; Rats, Wistar; Rivastigmine; Rotarod Performance Test | 2009 |
Rivastigmine in the treatment of Huntington's disease.
Topics: Carbamates; Cholinesterase Inhibitors; Humans; Huntington Disease; Phenylcarbamates; Rivastigmine | 2002 |